New urine test could spare bladder cancer patients from needless treatment

NCT ID NCT04564781

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 27 times

Summary

This study is testing a new urine test to see if it can predict which bladder cancer patients will respond well to a standard treatment called BCG. Currently, about half of patients do not respond to BCG, leading to more treatments or surgery. The goal is to use this test to help doctors choose the right treatment from the start. The study involves 400 adults with intermediate or high-risk non-muscle invasive bladder cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cedars-Sinai Medical Center

    RECRUITING

    Los Angeles, California, 90048, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Kyoto University

    RECRUITING

    Kyoto, Kyoto, 606-8501, Japan

    Contact

  • UCLA

    RECRUITING

    Los Angeles, California, 90095, United States

    Contact

  • UCSF

    RECRUITING

    San Francisco, California, 94143, United States

    Contact

  • University of Texas Southwestern

    RECRUITING

    Dallas, Texas, 75390, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.